Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME

Inclusion Criteria: 1. Age ≥ 18 years and Older. 2. Diagnosis of diabetes mellitus (type 1 or type 2). 3. At least one eye meets the study eye criteria listed. 4. Visual Acuity 20/30 - 20/200 Snellen equivalent 5. Have received no previous treatment for diabetic macular edema,(treatment naïve) 6. Mild to Severe Non-proliferative Diabetic Retinopathy 7. Diabetic macular edema present on optical coherence tomography (OCT) central subfield: ≥ 300µm. 8. Able and willing to provide informed consent. Exclusion Criteria: 1. Have had any prior ocular treatment. 2. Have had prior retinal surgical ( i.e. Pars plana vitrectomy). 3 .Have any clinical evidence of proliferative diabetic retinopathy. 4\. Have a HBA1c of greater of 10%. 5. Evidence of Glaucoma or who are labeled glaucoma suspect at screening (defined as C/D \>/= 0.5 with correlated NFLA thinning or IOP\>25mmHg). 6. Have a contraindication to Ozurdex.